Jennifer Trendell

5PUBLICATIONS
69CO-AUTHORS
Molecular targetsCancer diagnosisHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 22, 2026
The anion channel GPR89 is a tumor-specific dependency in breast cancer.

|Sep 21, 2026
PUM3 is an essential suppressor of replication stress in homologous recombination deficient breast cancer.

|Mar 12, 2026
Tumour specific HORMAD1 expression perturbs mitotic arrest and drives sensitivity to mitotic kinase inhibitors.

Callum Walker, Gabriel Kollarovic, Daniel Weekes

|Oct 23, 2025
An Fc-Engineered Glycomodified Antibody Supports Proinflammatory Activation of Immune Effector Cells and Restricts Progression of Breast Cancer.

Alicia M Chenoweth, Anthony Cheung, Jitesh Chauhan

|May 21, 2024
Anti-EGFR Antibody-Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth.

Anthony Cheung, Alicia M Chenoweth, Annelie Johansson

Pageof 1

Frequent Collaborators

5 joint publications

Anita Grigoriadis

5 joint publications

Andrew Tutt

5 joint publications

Syed Haider

4 joint publications

Christopher J Lord